Filtros de búsqueda

Lista de obras de Richard Dodel

A Consensus Set of Outcomes for Parkinson's Disease from the International Consortium for Health Outcomes Measurement

artículo científico publicado en 2017

A multicentre RCT on community occupational therapy in Alzheimer's disease: 10 sessions are not better than one consultation

artículo científico publicado en 2011

A novel V272D presenilin mutation associated with logopenia, disorientation, and apraxia in an autosomal-dominant Alzheimer's disease family

artículo científico publicado en 2019

A polymorphism in the cystatin C promoter region is not associated with an increased risk of AD.

artículo científico publicado en 2002

A polymorphism in the intronic region of the IL-1alpha gene and the risk for Parkinson's disease

artículo científico publicado en 2001

APP transgenic mice: the effect of active and passive immunotherapy in cognitive tasks

artículo científico publicado en 2009

Activation mapping in essential tremor with functional magnetic resonance imaging

artículo científico publicado en 1997

Activation of KCNN3/SK3/K(Ca)2.3 channels attenuates enhanced calcium influx and inflammatory cytokine production in activated microglia.

artículo científico publicado en 2012

Activation of a caspase 3-related cysteine protease is required for glutamate-mediated apoptosis of cultured cerebellar granule neurons

artículo científico publicado el 14 de octubre de 1997

Affective and cognitive Theory of Mind in patients with parkinson's disease

artículo científico publicado en 2010

Aiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal Studies

artículo científico publicado en 2016

Alpha2 macroglobulin and the risk of Alzheimer's disease.

artículo científico publicado en 2000

Alpha2-macroglobulin attenuates beta-amyloid peptide 1-40 fibril formation and associated neurotoxicity of cultured fetal rat cortical neurons.

artículo científico publicado en 1998

Alpha2-macroglobulin, lipoprotein receptor-related protein and lipoprotein receptor-associated protein and the genetic risk for developing Alzheimer's disease.

artículo científico publicado en 2006

An economic evaluation of deep brain stimulation for patients with Parkinson's disease

artículo científico publicado en 2016

An interleukin-6 promoter variant is not associated with an increased risk for Alzheimer's disease

artículo científico publicado en 2004

Antibody-based therapy in Alzheimer's disease

artículo científico publicado el 25 de enero de 2011

Antidepressant medication in a German cohort of patients with Alzheimer's disease

scholarly article by Philipp Hessmann et al published 1 March 2018 in International Journal of Clinical Pharmacology and Therapeutics

Antipsychotic treatment of community-dwelling and institutionalised patients with dementia in Germany

artículo científico publicado en 2017

Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease

artículo científico publicado en 1999

Apolipoprotein E ε4 does not affect cognitive performance in patients with Parkinson's disease

artículo científico publicado en 2016

Assessing health-related quality of life in patients with Parkinson's disease in a prospective longitudinal study

artículo científico publicado en 2006

Assessing health-related quality of life in patients with restless legs syndrome

artículo científico publicado en 2008

Association between longitudinal clinical outcomes in patients with hip fracture and their pre-fracture place of residence

artículo científico publicado en 2019

Association of an interleukin 1 alpha polymorphism with Alzheimer's disease

scientific article published on 01 August 2000

Association of clusterin gene polymorphisms with late-onset Alzheimer's disease.

artículo científico publicado en 2011

Awareness and knowledge of the clinical practice guideline on Parkinson's disease among German neurologists

artículo científico publicado en 2009

Benchmarking in patient care: depression in Parkinson's disease

scientific article published on 16 June 2011

Blood-based protein biomarkers for diagnosis and classification of neurodegenerative diseases: current progress and clinical potential

artículo científico publicado en 2011

Bupropion for the Treatment of Apathy in Alzheimer Disease: A Randomized Clinical Trial

artículo científico publicado en 2020

C/T conversion alters interleukin-1A promoter function in a human astrocyte cell line

artículo científico publicado en 2006

CNI-1493 inhibits Abeta production, plaque formation, and cognitive deterioration in an animal model of Alzheimer's disease.

artículo científico publicado en 2008

CSF cortisol in Alzheimer's disease and mild cognitive impairment.

artículo científico publicado en 2007

Cabergoline versus levodopa monotherapy: a decision analysis

artículo científico publicado en 2003

Caffeic acid phenethyl ester blocks free radical generation and 6-hydroxydopamine-induced neurotoxicity

artículo científico publicado en 2006

Caffeic acid phenethyl ester prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration

artículo científico publicado en 2011

Caffeic acid phenethyl ester prevents cerebellar granule neurons (CGNs) against glutamate-induced neurotoxicity

artículo científico publicado en 2008

Caffeic acid phenethyl ester prevents neonatal hypoxic-ischaemic brain injury

artículo científico publicado en 2004

Caregiver Burden in Late-Stage Parkinsonism and Its Associations

artículo científico publicado en 2020

Caspase-3-like proteases and 6-hydroxydopamine induced neuronal cell death

artículo científico publicado en 1999

Centenary of Lewy bodies (1912-2012).

artículo científico

Characteristics of Patients with Late-Stage Parkinsonism who are Nursing Home Residents Compared with those Living at Home

artículo científico publicado en 2020

Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria

artículo científico publicado en 2017

Cognitive decline in Parkinson's disease: the impact of the motor phenotype on cognition

artículo científico publicado en 2018

Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD).

artículo científico publicado en 2008

Comparative responsiveness of Parkinson's disease scales to change over time.

artículo científico publicado en 2009

Comparing the neural correlates of affective and cognitive theory of mind using fMRI: Involvement of the basal ganglia in affective theory of mind

artículo científico publicado en 2013

Comparison of intravenous immunoglobulins for naturally occurring autoantibodies against amyloid-beta

scientific article published on 01 January 2010

Copper deficiency associated with severe neurological disorder--a genetic work-up of possible mutations in copper transport proteins

scientific article published on 11 February 2010

Corrigendum to “Cost of disorders of the brain in Europe 2010” [Eur. Neuropsychopharmacol. 21 (2011) 718–779]

artículo científico publicado en 2012

Cost and care of patients with Alzheimer's disease: clinical predictors in German health care settings

artículo científico publicado en 2011

Cost effectiveness of pharmacotherapies in early Parkinson's disease

artículo científico publicado en 2008

Cost of disorders of the brain in Europe 2010.

artículo científico publicado en 2011

Cost of epilepsy: a systematic review

artículo científico publicado en 2008

Cost of illness and health service patterns in Morbus Parkinson in Austria

artículo científico publicado en 2009

Cost of illness and its predictors for Parkinson's disease in Germany

scientific article published on 01 January 2005

Cost of illness in Parkinson disease. A retrospective 3-month analysis of direct costs

artículo científico publicado en 1997

Cost of illness in patients with Gilles de la Tourette's syndrome

artículo científico publicado en 2010

Cost of illness in subarachnoid hemorrhage: a German longitudinal study

artículo científico publicado en 2010

Cost-effectiveness of deep brain stimulation in patients with Parkinson's disease

artículo científico publicado en 2013

Cost-effectiveness of neurostimulation in Parkinson's disease with early motor complications

artículo científico publicado en 2016

Cost-of-illness in multiple system atrophy and progressive supranuclear palsy

artículo científico publicado en 2011

Costs and cost-driving factors for acute treatment of adults with status epilepticus: A multicenter cohort study from Germany

artículo científico publicado en 2016

Costs of Parkinson's disease and antiparkinsonian pharmacotherapy: an Italian cohort study

artículo científico publicado en 2010

Costs of Parkinson's disease in eastern Europe: a Czech cohort study

artículo científico publicado en 2009

Costs of acute stroke care on regular neurological wards: a comparison with stroke unit setting.

artículo científico publicado en 2006

Costs of drug treatment in Parkinson's disease

artículo científico publicado en 1998

Costs of drug treatment of neurologic diseases: Parkinson disease, dystonia, epilepsy

artículo científico publicado en 1996

Costs of epilepsy and cost-driving factors in children, adolescents, and their caregivers in Germany

artículo científico publicado en 2015

Costs of epilepsy and their predictors: Cross-sectional study in Germany and review of literature

article

Costs of illness and care in Parkinson's disease: an evaluation in six countries

scientific article published on 01 February 2011

Costs of illness in a Russian cohort of patients with Parkinson's disease.

artículo científico publicado en 2009

Costs of illness in chronic inflammatory demyelinating polyneuropathy in Germany

artículo científico publicado en 2018

Costs of treating dystonias and hemifacial spasm with botulinum toxin A.

artículo científico publicado en 1997

Decreased serum amyloid beta(1-42) autoantibody levels in Alzheimer's disease, determined by a newly developed immuno-precipitation assay with radiolabeled amyloid beta(1-42) peptide.

artículo científico publicado en 2005

Dementia and depression determine care dependency in Parkinson's disease: analysis of 1,449 outpatients receiving nursing care in Germany

artículo científico publicado en 2011

Depression and care-dependency in Parkinson's disease: results from a nationwide study of 1449 outpatients

artículo científico publicado en 2011

Diagnosis and treatment of cognitive impairment

scientific article published on 03 June 2019

Differentially expressed gene profile in the 6-hydroxy-dopamine-induced cell culture model of Parkinson's disease

artículo científico publicado en 2011

Differently selected D-enantiomeric peptides act on different Abeta species

artículo científico publicado en 2010

Direct and indirect costs of refractory epilepsy in a tertiary epilepsy center in Germany

artículo científico publicado en 2006

Dopamine transporter imaging and SPECT in diagnostic work-up of Parkinson's disease: A decision-analytic approach

artículo científico publicado el 1 de octubre de 2003

Early signs of VCP-related frontotemporal dementia: a neuropsychological, FDG-PET and fMRI study

scholarly article by Elke Kalbe et al published 12 October 2010 in Journal of Neurology

Economic burden in a German cohort of patients with multiple sclerosis

artículo científico publicado en 2011

Economic evaluation of treatment options in patients with Alzheimer's disease: a systematic review of cost-effectiveness analyses.

artículo científico publicado en 2012

Effect of Preexisting Cognitive Impairment on In-Patient Treatment and Discharge Management among Elderly Patients with Hip Fractures

artículo científico publicado en 2015

Effect of minocycline in experimental autoimmune encephalomyelitis

artículo científico publicado en 2002

Effect of naturally occurring α-synuclein-antibodies on toxic α-synuclein-fragments

artículo científico publicado en 2019

Encoding the Sequence of Specific Autoantibodies Against beta-Amyloid and alpha-Synuclein in Neurodegenerative Diseases

artículo científico publicado en 2019

Evaluation of costs and outcome in cardioembolic stroke or TIA

scientific article published on 01 March 2009

Evaluation of health-care utilization among adult patients with epilepsy in Germany

artículo científico publicado en 2012

Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.

artículo científico publicado en 2002

Evaluation of the obesity genes FTO and MC4R and the type 2 diabetes mellitus gene TCF7L2 for contribution to stroke risk: The Mannheim-Heidelberg Stroke Study.

artículo científico publicado en 2011

Extending the functional characteristics of naturally occurring autoantibodies against β-Amyloid, Prion Protein and α-Synuclein

artículo científico publicado en 2018

Factors influencing the progress of mobilization in hip fracture patients during the early postsurgical period?-A prospective observational study

artículo científico publicado en 2015

Frequency and treatment of depressive symptoms in a Parkinson's disease registry

artículo científico publicado en 2008

Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson's disease

artículo científico publicado en 2010

Health economic burden of patients with restless legs syndrome in a German ambulatory setting

artículo científico publicado en 2010

Health-Related Quality of Life in Patients with Alzheimer's Disease in Different German Health Care Settings

artículo científico publicado en 2016

Health-Related Quality of Life in patients with Parkinson's disease--A systematic review based on the ICF model

artículo científico publicado en 2015

Health-related quality of life and economic burden in patients with restless legs syndrome

artículo científico publicado en 2007

Health-related quality of life and healthcare utilisation in patients with Parkinson's disease: impact of motor fluctuations and dyskinesias

artículo científico publicado en 2001

Health-related quality of life and its determinants in Parkinson’s disease: Results of an Italian cohort study

artículo científico publicado el 9 de febrero de 2011

Health-related quality of life and its determinants in the urban Russian population with major depressive disorder: a cross-sectional study

artículo científico publicado en 2012

Health-related quality of life in ALS, myasthenia gravis and facioscapulohumeral muscular dystrophy

artículo científico publicado en 2010

Health-related quality of life in multiple system atrophy and progressive supranuclear palsy

artículo científico publicado en 2011

Health-related quality of life in patients with Gilles de la Tourette's syndrome

artículo científico publicado en 2010

Health-related quality of life in patients with a history of myocardial infarction and stroke

artículo científico publicado en 2010

Health-related quality of life in patients with narcolepsy.

artículo científico publicado en 2007

Health-related quality of life in patients with subarachnoid haemorrhage

artículo científico publicado en 2010

Heat shock protein 60: an endogenous inducer of dopaminergic cell death in Parkinson disease

artículo científico publicado en 2014

Human anti-beta-amyloid antibodies block beta-amyloid fibril formation and prevent beta-amyloid-induced neurotoxicity

artículo científico publicado en 2003

Human anti-prion antibodies block prion peptide fibril formation and neurotoxicity

artículo científico publicado en 2012

Human antibodies against amyloid beta peptide: a potential treatment for Alzheimer's disease.

artículo científico publicado en 2002

IFATS collection: The conditioned media of adipose stromal cells protect against hypoxia-ischemia-induced brain damage in neonatal rats

artículo científico publicado en 2009

IVIG Delays Onset in a Mouse Model of Gerstmann-Sträussler-Scheinker Disease.

artículo científico publicado en 2018

Immune checkpoint inhibitor-associated CNS autoimmune disorder (ICICAD) following nivolumab treatment: A new entity of drug-induced autoimmune encephalitis?

artículo científico publicado en 2017

Immunization as treatment for Parkinson's disease.

artículo científico publicado en 2009

Immunotherapy and naturally occurring autoantibodies in neurodegenerative disorders

artículo científico publicado en 2008

Immunotherapy for Alzheimer's disease

scientific article published on 01 April 2003

Immunotherapy in prion disease

artículo científico

Impact of complications and comorbidities on treatment costs and health-related quality of life of patients with Parkinson's disease

artículo científico publicado en 2011

Improve hip fracture outcome in the elderly patient (iHOPE): a study protocol for a pragmatic, multicentre randomised controlled trial to test the efficacy of spinal versus general anaesthesia

article published in 2018

In vivo markers of Parkinson's disease and dementia with Lewy bodies: current value of the 5G4 α-synuclein antibody

artículo científico publicado en 2014

Incidence of Parkinson's disease and atypical parkinsonism: Russian population-based study.

artículo científico publicado en 2010

International guide to drugs for Parkinson's disease

artículo científico publicado en 1995

Intravenous Immunoglobulins as a Treatment for Alzheimerʼs Disease

artículo científico publicado en 2010

Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial

artículo científico publicado en 2013

Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's disease

artículo científico publicado en 2004

Involvement of a Caspase‐3‐Like Cysteine Protease in 1‐Methyl‐4‐Phenylpyridinium‐Mediated Apoptosis of Cultured Cerebellar Granule Neurons

artículo científico publicado el 1 de octubre de 1997

Is there underfunding in brain research? The UK research expenditure

artículo científico publicado en 2011

Is treatment of geriatric hip fracture patients cost-covering? Results of a prospective study conducted at a German University Hospital

artículo científico publicado en 2017

Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition

artículo científico publicado el 1 de noviembre de 1997

Lack of association between the interleukin-1 alpha (-889) polymorphism and early-onset Parkinson's disease

artículo científico publicado en 2004

Lack of association of interleukin-10 promoter region polymorphisms with Alzheimer's disease

artículo científico publicado el 15 de mayo de 2003

Lewy body dementia and Parkinson's disease with dementia

artículo científico publicado en 2008

Long-Term Cognitive Decline Related to the Motor Phenotype in Parkinson’s Disease

artículo científico publicado en 2022

Long-term outcome after stroke: evaluating health-related quality of life using utility measurements

scientific article published on 08 December 2005

Longitudinal brain atrophy distribution in advanced Parkinson's disease: What makes the difference in "cognitive status" converters?

scientific article published on 02 December 2019

Longitudinal study of the socioeconomic burden of Parkinson's disease in Germany

artículo científico publicado en 2010

Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer's disease

artículo científico publicado en 2009

Macrophage migration inhibitory factor in normal human skeletal muscle and inflammatory myopathies

artículo científico publicado en 2010

Mapping the EQ-5D index by UPDRS and PDQ-8 in patients with Parkinson's disease

artículo científico publicado en 2013

Measurement of costs and scales for outcome evaluation in health economic studies of Parkinson's disease

artículo científico

Measuring Compounds in Exhaled Air to Detect Alzheimer's Disease and Parkinson's Disease

artículo científico publicado en 2015

Mechanisms of action of naturally occurring antibodies against β-amyloid on microglia

artículo científico publicado en 2013

Methods in Neuroepidemiology Characterization of European Longitudinal Cohort Studies in Parkinson's Disease--Report of the JPND Working Group BioLoC-PD.

artículo científico publicado en 2015

Midregional Proenkephalin A and N-terminal Protachykinin A are decreased in the cerebrospinal fluid of patients with dementia disorders and acute neuroinflammation.

artículo científico publicado en 2010

Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and [(11)C] (R)-PK11195 PET (MEMSA-trial).

artículo científico publicado en 2010

Minocycline blocks 6-hydroxydopamine-induced neurotoxicity and free radical production in rat cerebellar granule neurons

artículo científico publicado en 2003

Minocycline prevents gentamicin-induced ototoxicity by inhibiting p38 MAP kinase phosphorylation and caspase 3 activation

artículo científico publicado en 2005

Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease

artículo científico publicado en 2001

Modelling the cost effectiveness of treatments for Parkinson's disease: a methodological review

artículo científico

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan

article

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results

article

NF-kappaB mediates IL-1beta-induced synthesis/release of alpha2-macroglobulin in a human glial cell line

artículo científico publicado en 2002

Naturally Occurring Autoantibodies against Tau Protein Are Reduced in Parkinson's Disease Dementia

artículo científico publicado en 2016

Naturally occurring alpha-synuclein autoantibodies in Parkinson's disease: sources of (error) variance in biomarker assays

artículo científico publicado en 2014

Naturally occurring autoantibodies against beta-amyloid: investigating their role in transgenic animal and in vitro models of Alzheimer's disease.

artículo científico publicado en 2011

Naturally occurring autoantibodies against β-Amyloid

artículo científico publicado en 2012

Naturally occurring autoantibodies interfere with β-amyloid metabolism and improve cognition in a transgenic mouse model of Alzheimer's disease 24 h after single treatment

artículo científico publicado en 2013

Naturally occurring α-synuclein autoantibody levels are lower in patients with Parkinson disease

artículo científico publicado en 2012

Neurogeriatrics-a vision for improved care and research for geriatric patients with predominating neurological disabilities

scientific article published on 19 May 2020

No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors

scholarly article by Franziska Hopfner et al published 2019 in Translational Neurodegeneration

Occurrence risk and structure of depression in Parkinson disease with and without dementia: results from the GEPAD Study.

artículo científico publicado en 2009

Once-daily transdermal rivastigmine in the treatment of Alzheimer's disease.

artículo científico publicado en 2009

Optimizing Treatment in Undertreated Late-Stage Parkinsonism: A Pragmatic Randomized Trial

scientific article published on 18 June 2020

Pallidal lesions. Structural and functional magnetic resonance imaging

artículo científico publicado en 1996

Parkinson's disease: cost-of-illness in an outpatient cohort

artículo científico publicado en 2010

Parkinson's syndrome in a young patient with Klinefelter's syndrome--a case report

scientific article published on 01 April 2008

Parkinson’s Disease and Dementia: A Longitudinal Study (DEMPARK)

scholarly article by Monika Balzer-Geldsetzer et al published 2011 in Neuroepidemiology

Pathogenic and physiological autoantibodies in the central nervous system

artículo científico publicado en 2012

Peptide inhibitors of caspase-3-like proteases attenuate 1-methyl-4-phenylpyridinum-induced toxicity of cultured fetal rat mesencephalic dopamine neurons

artículo científico publicado en 1998

Peripheral and central biodistribution of (111)In-labeled anti-beta-amyloid autoantibodies in a transgenic mouse model of Alzheimer's disease.

artículo científico publicado en 2008

Pharmacoeconomic considerations of treating patients with advanced Parkinson's disease

artículo científico publicado en 2012

Pharmacotherapy of Parkinson's disease in Germany

artículo científico publicado en 2005

Predictors of noninstitutionalized survival 1 year after hip fracture: A prospective observational study to develop the Marburg Rehabilitation Tool for Hip fractures (MaRTHi).

artículo científico publicado en 2017

Preference-based Health status in a German outpatient cohort with multiple sclerosis

artículo científico publicado en 2013

Prescription of Benzodiazepines and Related Drugs in Patients with Mild Cognitive Deficits and Alzheimer's Disease

artículo científico publicado en 2018

Prevalence and incidence of Parkinson's disease in Europe

artículo científico publicado en 2005

Prevalence, Duration and Severity of Parkinson's Disease in Germany: A Combined Meta-Analysis from Literature Data and Outpatient Samples

artículo científico publicado en 2017

Prevalence, utilization, and costs of antiepileptic drugs for epilepsy in Germany--a nationwide population-based study in children and adults

artículo científico publicado en 2012

Prion peptide uptake in microglial cells--the effect of naturally occurring autoantibodies against prion protein

artículo científico publicado en 2013

Procalcitonin is elevated in the cerebrospinal fluid of patients with dementia and acute neuroinflammation

scientific article published on 15 August 2007

Prodromal Markers in Parkinson's Disease: Limitations in Longitudinal Studies and Lessons Learned

artículo científico publicado en 2016

Projected numbers of people with movement disorders in the years 2030 and 2050.

artículo científico publicado en 2011

Psychiatric symptoms in Parkinson’s disease

scholarly article by Frank Schneider et al published November 2008 in European Archives of Psychiatry and Clinical Neuroscience

Psychometric Properties of an Abbreviated Version of the Apathy Evaluation Scale for Parkinson Disease (AES-12PD)

scholarly article by Yuliya Stankevich et al published October 2018 in American Journal of Geriatric Psychiatry

Psychometric properties of the apathy evaluation scale in patients with Parkinson's disease.

artículo científico publicado en 2017

Rapid detection of a pentanucleotide deletion polymorphism in the human alpha2-macroglobulin gene

artículo científico publicado en 1999

Rate of clinical progression in Parkinson's disease. A prospective study.

artículo científico publicado en 2007

Re-admission to Level 2 unit after hip-fracture surgery - Risk factors, reasons and outcome

artículo científico publicado en 2013

Red flags for multiple system atrophy

artículo científico publicado en 2008

Reduced levels of amyloid beta-peptide antibody in Alzheimer disease

artículo científico publicado en 2001

Reducing sample complexity of polyclonal human autoantibodies by chromatofocusing

artículo científico publicado en 2010

Reduction of glutamate-induced excitotoxicity in murine primary neurons involving calpain inhibition

artículo científico publicado en 2015

Reply

scientific article published on 29 January 2019

Resource utilization and costs of stroke unit care in Germany

artículo científico publicado en 2004

Restoration of contact inhibition in human glioblastoma cell lines after MIF knockdown

artículo científico publicado en 2009

Role of MIF in inflammation and tumorigenesis

scientific article published on 15 September 2008

Role of dopamine transporter SPECT for the practitioner and the general neurologist

artículo científico publicado el 1 de octubre de 2003

Role of macrophage migration inhibitory factor in primary glioblastoma multiforme cells

artículo científico publicado en 2011

SK channel activation modulates mitochondrial respiration and attenuates neuronal HT-22 cell damage induced by H2O2.

artículo científico publicado en 2015

Safety and efficacy of perampanel in advanced Parkinson's disease: a randomized, placebo-controlled study

artículo científico publicado en 2010

Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument

artículo científico publicado en 2007

Serum titers of autoantibodies against α-synuclein and tau in child- and adulthood

artículo científico publicado en 2017

Social and clinical determinants of quality of life in Parkinson's disease in Austria: a cohort study.

artículo científico publicado en 2009

Social and clinical determinants of quality of life in Parkinson's disease in a Russian cohort study

artículo científico publicado en 2009

Socioeconomic burden of amyotrophic lateral sclerosis, myasthenia gravis and facioscapulohumeral muscular dystrophy

artículo científico publicado en 2009

Sodium salicylate and 17beta-estradiol attenuate nuclear transcription factor NF-kappaB translocation in cultured rat astroglial cultures following exposure to amyloid A beta(1-40) and lipopolysaccharides

artículo científico publicado en 1999

Structural brain signature of cognitive decline in Parkinson's disease: DTI-based evidence from the LANDSCAPE study.

artículo científico publicado en 2019

Structured relearning of activities of daily living in dementia: the randomized controlled REDALI-DEM trial on errorless learning

artículo científico publicado en 2017

Study protocol: Care of Late-Stage Parkinsonism (CLaSP): a longitudinal cohort study

scholarly article by Monika Balzer-Geldsetzer et al published 5 November 2018 in BMC Neurology

Subtypes of mild cognitive impairment in patients with Parkinson's disease: evidence from the LANDSCAPE study

artículo científico publicado en 2016

Synthesis of a biological active β-hairpin peptide by addition of two structural motifs

artículo científico publicado en 2016

Synthetic dimeric Aβ(28-40) mimics the complex epitope of human anti-Aβ autoantibodies against toxic Aβ oligomers

artículo científico publicado en 2013

Systematic assessment of decision models in Parkinson's disease.

artículo científico publicado en 2004

TREM2 rare variant p.R47H is not associated with Parkinson's disease

artículo científico publicado en 2015

The European Multiple System Atrophy-Study Group (EMSA-SG).

artículo científico publicado en 2005

The NF-kappaB/Rel family of proteins mediates Abeta-induced neurotoxicity and glial activation

artículo científico publicado en 1998

The Prevalence and Determinants of Neuropsychiatric Symptoms in Late-Stage Parkinsonism

artículo científico publicado en 2020

The economic benefit of a timely, adequate, and adherent Parkinson's disease treatment. - The value of treatment project 2

scientific article published on 13 October 2020

The economic impact of Parkinson's disease. An estimation based on a 3-month prospective analysis

artículo científico publicado en 1998

The endogenous α7 nicotinic acetylcholine receptor antagonist kynurenic acid modulates amyloid-β-induced inflammation in BV-2 microglial cells

artículo científico publicado en 2014

The flavanoide caffeic acid phenethyl ester blocks 6-hydroxydopamine-induced neurotoxicity

artículo científico publicado en 2005

The future of Alzheimer's disease: the next 10 years

artículo científico publicado en 2011

The natural history of multiple system atrophy: a prospective European cohort study

artículo científico publicado en 2013

The neuroprotective role of microglial cells against amyloid beta-mediated toxicity in organotypic hippocampal slice cultures

scientific article published on 26 November 2019

The role of CNI-1493 in the function of primary microglia with respect to amyloid-β.

artículo científico publicado en 2011

The role of choroid plexus in IVIG-induced beta-amyloid clearance

artículo científico publicado en 2014

The role of macrophage inhibitory factor in tumorigenesis and central nervous system tumors

scientific article published on May 2009

The role of macrophage migration inhibitory factor in Alzheimer's disease

artículo científico publicado en 2010

The socioeconomic impact of narcolepsy

artículo científico publicado en 2004

The α7 nAChR agonist PNU-282987 reduces inflammation and MPTP-induced nigral dopaminergic cell loss in mice

artículo científico publicado en 2013

Theory of mind in Parkinson's disease and related basal ganglia disorders: a systematic review

artículo científico publicado en 2010

Therapy of Alzheimer's disease: current status and future development

artículo científico publicado en 2008

Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease

artículo científico publicado en 2013

Trajectory classes of decline in health-related quality of life in Parkinson's disease: a pilot study

artículo científico publicado en 2011

Treatment of hypersexuality in Parkinson's disease with carbamazepine--a case report

artículo científico publicado en 2009

Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany

artículo científico publicado en 2013

Trends in resource utilization for Parkinson's disease in Germany

artículo científico publicado en 2010

Use of antidementia drugs in German patients with Alzheimer's disease

artículo científico publicado en 2017

Which ante mortem clinical features predict progressive supranuclear palsy pathology?

artículo científico publicado en 2017

Who was the man who discovered the “Lewy bodies”?

artículo científico publicado el 15 de septiembre de 2010

Widespread microglial activation in multiple system atrophy

[Dementia with Lewy bodies]

artículo científico publicado en 2018

[Differences Between Self- and Proxy-Assessment of Health-Related Quality of Life in Patients with Mild Cognitive Impairment and Alzheimer's Disease].

artículo científico publicado en 2017

[Direct costs for Parkinson's treatment in private neurology practices in Berlin].

artículo científico publicado en 2009

[Early diagnosis of dementia]

scientific article published on 01 April 2020

[Health-economic burden of Parkinson's disease in Portugal: a cohort study].

artículo científico publicado en 2011

[Inclusion Body Myopathy, Paget's Disease, and Fronto-temporal Dementia: a VCP-related Multi-systemic Proteinopathy]

artículo científico publicado en 2018

[Memory clinics in Germany-structural requirements and areas of responsibility]

scientific article published on 06 October 2020

[The costs of epilepsy in Germany]

artículo científico publicado en 2007

alpha2-Macroglobulin as a beta-amyloid peptide-binding plasma protein.

artículo científico publicado en 1997

α1-antitrypsin modulates microglial-mediated neuroinflammation and protects microglial cells from amyloid-β-induced toxicity.

artículo científico publicado en 2014